CINECA IRIS Institutional Research Information System

MENCONI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.124
AS - Asia 1.466
EU - Europa 1.217
SA - Sud America 194
AF - Africa 90
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.096
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.042
SG - Singapore 511
CN - Cina 368
SE - Svezia 291
IT - Italia 287
HK - Hong Kong 233
DE - Germania 168
BR - Brasile 154
VN - Vietnam 132
FR - Francia 96
GB - Regno Unito 82
BG - Bulgaria 75
CA - Canada 48
FI - Finlandia 44
IN - India 42
RU - Federazione Russa 39
AT - Austria 38
CI - Costa d'Avorio 38
TR - Turchia 38
JP - Giappone 29
SN - Senegal 22
BD - Bangladesh 19
NL - Olanda 19
IQ - Iraq 18
UA - Ucraina 18
MX - Messico 12
SA - Arabia Saudita 12
ZA - Sudafrica 12
AR - Argentina 10
PL - Polonia 10
PK - Pakistan 9
VE - Venezuela 9
ES - Italia 8
IE - Irlanda 8
BE - Belgio 7
PH - Filippine 7
ID - Indonesia 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CO - Colombia 5
CR - Costa Rica 5
LT - Lituania 5
PS - Palestinian Territory 5
AU - Australia 4
CL - Cile 4
UZ - Uzbekistan 4
DO - Repubblica Dominicana 3
EC - Ecuador 3
EG - Egitto 3
GR - Grecia 3
JM - Giamaica 3
LB - Libano 3
PA - Panama 3
RO - Romania 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
BS - Bahamas 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SR - Suriname 1
TH - Thailandia 1
TW - Taiwan 1
Totale 6.096
Salva come PNG Salva come JPEG
Città #
Dallas 355
Ashburn 353
Woodbridge 262
Singapore 245
Hong Kong 229
San Jose 228
Fairfield 219
Houston 167
Santa Clara 151
Chandler 139
Ann Arbor 107
Seattle 92
Beijing 82
Sofia 75
Shanghai 72
Wilmington 72
Los Angeles 70
New York 68
Serra 66
Cambridge 61
Munich 59
Florence 42
Abidjan 38
London 36
Boardman 35
Ho Chi Minh City 34
Vienna 34
Ottawa 33
Princeton 32
Lawrence 27
Bremen 26
Frankfurt am Main 26
Hanoi 24
Lauterbourg 24
Medford 24
Tokyo 24
Turku 23
Dakar 22
Istanbul 19
Pisa 19
Des Moines 18
Dong Ket 18
Rome 18
Buffalo 17
Marseille 17
Redondo Beach 17
Chicago 16
Dearborn 15
Milan 14
Nanjing 14
Ogden 14
Orem 14
Lancaster 13
Atlanta 12
Düsseldorf 11
Chennai 10
Denver 10
Izmir 10
Baghdad 9
Helsinki 9
Johannesburg 9
Lucca 9
São Paulo 9
Warsaw 9
Montreal 8
Nanchang 8
San Diego 8
Brussels 7
Fuzhou 7
Kunming 7
Manchester 7
Riyadh 7
Baltimore 6
Cagliari 6
Changsha 6
Columbus 6
Dhaka 6
Dublin 6
Guangzhou 6
Paris 6
Poplar 6
Tianjin 6
Amsterdam 5
Gaza 5
Hebei 5
Houten 5
Jacksonville 5
Jinan 5
Portsmouth 5
Rio de Janeiro 5
San Francisco 5
Stockholm 5
Aosta 4
Baku 4
Belo Horizonte 4
Brooklyn 4
Da Nang 4
Haiphong 4
Hercules 4
Jüchen 4
Totale 4.227
Salva come PNG Salva come JPEG
Nome #
Natural history of graves’ orbitopathy after treatment 269
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 223
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 222
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 220
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 219
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 217
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 191
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 190
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO) 188
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma 179
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 174
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study 174
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 157
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 156
PREGO ( presentation of Graves' orbitopathy) study: Changes in referral patterns to European Group on Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 148
Combined mycophenolate + prednisolone therapy is more effective than prednisolone in active and moderate-to-severe Graves’ Orbitopathy – A randomized, observer blind, multicenter trial 148
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 144
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 142
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathy 136
Functional outcomes and complications in refractory dysthyroid optic neuropathy management: Experience with 3 different surgical protocols 134
Selenium in Graves Hyperthyroidism and Orbitopathy 132
Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimus 127
null 121
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 111
Sirolimus as a second-line treatment for Graves' orbitopathy 109
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 109
IgG4 serum levels in Graves' orbitopathy 104
null 100
Long-term outcome of Graves’ orbitopathy following treatment with sirolimus 97
Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort Study 95
null 95
null 93
Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy 92
null 91
Insights Into the Role of DNA Methylation and Gene Expression in Graves Orbitopathy 89
null 88
Graves disease: latest understanding of pathogenesis and treatment options 86
Role of genetics and epigenetics in Graves’ orbitopathy 85
Absence of a relationship between vitamin D and Graves’ orbitopathy 77
Insights Into the Role of DNA Methylation and Gene Expression in Graves Orbitopathy 75
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study 74
null 70
Diagnosis and classification of Graves' disease 70
An update on the medical treatment of Graves' hyperthyroidism. 70
Role of genetic and non-genetic factors in the etiology of Graves' disease 67
null 65
null 57
Absence of a relationship between vitamin D and Graves’ orbitopathy 56
Total thyroid ablation in Graves' orbitopathy 49
Case Report: Familial partial lipodystrophy, description of novel and ultrarare variants with distinct phenotypic spectrum 15
null 3
null 1
null 1
Totale 6.205
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.189
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022446 1 6 5 41 88 49 3 18 65 68 3 99
2022/2023580 66 119 49 42 42 48 5 41 118 0 48 2
2023/2024218 7 10 24 8 26 58 4 16 3 3 34 25
2024/20251.348 10 33 16 56 119 137 94 47 130 174 168 364
2025/20262.036 164 243 333 166 216 136 275 99 93 184 66 61
2026/202761 61 0 0 0 0 0 0 0 0 0 0 0
Totale 6.205